These findings suggest that WTs with no WT1 abnormality may include a substantial number of tumours with IGF2-LOI, and that CTNNB1 mutation and IGF2-LOI may be mutually exclusive in WT and also in HB. The gene discussed is CTNNB1; the disease is hemoglobin measurement.